AzTrials
AzTrials

StrokePhase 1/2NCT00629005

Strength Training and Stroke

A Phase 1/2 study testing Constraint-Induced Movement Therapy + strength training and Constraint-Induced Movement Therapy + range of motion in people with Stroke, run by US Department of Veterans Affairs at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

People with stroke experience weakness and incoordination. Studies have shown that with functional task practice, people can increase motor control and strength to a certain extent. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Stroke
What is being tested?
Constraint-Induced Movement Therapy + strength training and Constraint-Induced Movement Therapy + range of motion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Feb 2008to Sep 2011
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 40-85;
  • a single unilateral middle cerebral artery ischemic stroke;
  • no history of drug/alcohol abuse;
  • ability to follow 3-step commands and provide informed consent;
  • no history of other neural disorder/dysfunction (including epilepsy), no serious medical illness or refractory depression;
  • at least 300 active upper extremity elevation in scapular plane (combination of flexion and abduction);
  • ability to extend the wrist 20 degrees, and two fingers and thumb 10 degrees three times in a minute;
  • permission of physician (BRRC medical director or BRRC neurologist) to participate in strength training.

Who cannot join

  • spasticity in elbow or hand (Modified Ashworth Scale > 2);
  • Motor Activity Log32 scores >3 (which would indicate relatively good use of the upper extremity);
  • ability to complete 135 degrees shoulder elevation easily with elbow straight (e.g., doesn't hold breath, movement is fluid, little to no effort tremor observed);
  • ataxia, major sensory deficits, or hemi-inattention/neglect;

Trial locations and contacts

1 site in 1 country.

United States1 site
  • North Florida/South Georgia Veterans Health System

    Gainesville, Florida, 32608

Other trials in United States

About this study

Official title: Should We Train Strength or Skill in Post-Stroke Rehabilitation?

People with stroke experience weakness and incoordination. Studies have shown that with functional task practice, people can increase motor control and strength to a certain extent. This study will investigate whether adding progressive resistance strength training to functional task practice modeled after Constraint-Induced Movement Therapy results in greater motor function gains than functional task practice alone

Read the detailed description

To date most investigations of UE rehabilitation have examined single interventions. However, combining 2 efficacious interventions may enhance effectiveness. Both functional task training and strength training are beneficial for promoting improved upper extremity function, but they have seldom been studied as a coupled therapy. The research proposed in this project will examine the effect on UE function of adding UE resistive exercises to functional task training. Secondary aims are to examine the effect of stroke severity on the response to therapy, the interrelationship between therapy-induced neural changes and movement composition and functional changes with therapy, and test for retention of UE function gains over 6 months. Individuals with chronic hemiparesis from stroke will complete baseline testing and then be randomly assigned to either the functional task + strength training group or the functional task training alone group. Each group will train 4 hours/day, 3 days/week for 4 weeks. Each will perform 3 hours of functional task training per session. The strengthening group will then complete 1 hour of UE progressive resistance exercises while the functional task training alone group will complete gravity eliminated range of motion exercises for 1 hour. All subjects will be post-tested and then complete follow-up testing 6 months later.

Conditions
Stroke
Being tested
Constraint-Induced Movement Therapy + strength training, Constraint-Induced Movement Therapy + range of motion
Keywords
rehabilitation, upper extremity, motor skills
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Constraint-Induced Movement Therapy + strength trainingBehavioural

    Also called forced use, functional task practice, progressive resistive exercise

    Participants wears a mitt on non-paretic hand for 90% of waking hours and completes 3 hours of functional task practice (e.g., flipping cards, putting coins in coin slot, putting cans on a shelf) plus 1 hour of resistance elastic band exercises

  • Constraint-Induced Movement Therapy + range of motionBehavioural

    Also called forced use, functional task practice

    Participants wears a mitt on non-paretic hand for 90% of waking hours and completes 3 hours of functional task practice (e.g., flipping cards, putting coins in coin slot, putting cans on a shelf) plus 1 hour of unresisted arm movements for

Study groups in NCT00629005
Study groupRoleWhat they receive
Arm 1ExperimentalConstraint-Induced Movement Therapy (wear a mitt on non-paretic hand for 90% of waking hours + functional task practice for 3 hours) plus 1 hour of strength training for the arms and hands 3x/week
Receives: Behavioral: Constraint-Induced Movement Therapy + strength training
Arm 2Active comparatorConstraint-Induced Movement Therapy (wear a mitt on non-paretic hand for 90% of waking hours + functional task practice for 3 hours) plus non-resisted arm and hand movements for 1 hour 3x/week
Receives: Behavioral: Constraint-Induced Movement Therapy + range of motion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Motor Assessment - UE Subscale

    Measured: Immediately after the end of therapy and 6 months later

Secondary outcomes (2)
  1. Wolf Motor Function Test

    Measured: Immediately after the end of therapy and 6 months later

  2. Cortical mapping using transcranial magnetic stimulation

    Measured: Immediately after the end of therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2008 (estimated)
  2. Study startFeb 2008
  3. Primary completionJul 2011
  4. Study completionSep 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00629005
Sponsor's protocol ID
B5033-W
Status last verified
Jan 2013
First submitted
19 Feb 2008
Last updated
29 Jan 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Constraint-Induced Movement Therapy + strength training and Constraint-Induced Movement Therapy + range of motion in people with Stroke, run by US Department of Veterans Affairs at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Motor Assessment - UE Subscale (time frame: Immediately after the end of therapy and 6 months later). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2013; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in